Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Masahiro, KIMATA"'
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 1, Pp 189-205 (2024)
Abstract Introduction Molnupiravir is an orally available prodrug of N-hydroxycytidine that received special approval for emergency treatment of coronavirus disease 2019 (COVID-19) in Japan in December 2021 and full approval in April 2023. To assess
Externí odkaz:
https://doaj.org/article/12654cc43f7c4201bc1c359f8b71c555
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 4, Pp 1119-1136 (2023)
Abstract Introduction Molnupiravir is an oral antiviral drug that received special approval for emergency use in Japan on December 24 2021 for infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This post-market
Externí odkaz:
https://doaj.org/article/646aa2b5a1e54ade83bf0ef8d55edae3
Autor:
Toshinobu Kato, Masahiro Kimata, Toshikazu Tsuji, Michitaka Shichijo, Masayuki Murata, Toru Miura, Isao Serizawa, Naoki Inagaki, Hiroichi Nagai
Publikováno v:
Allergology International, Vol 51, Iss 3, Pp 197-203 (2002)
Background: Although β-adrenergic receptor agonists inhibit antigen-induced release of histamine, leukotrienes and prostaglandin D2 from human lung fragments, dispersed human lung mast cells and human skin mast cells, subcellular mechanisms for the
Externí odkaz:
https://doaj.org/article/785d8520e9ce48ae9f3049dbb2c30022
Autor:
Masahiro Kimata
Publikováno v:
The Journal of The Institute of Electrical Engineers of Japan. 126:364-367
Publikováno v:
Allergology International. 55:67-76
Background Matrix metalloproteinases (MMPs) have been reported to play crucial roles in the migration of inflammatory cells through basement membrane components. To confirm the role of mast cells as a source of MMPs, we investigated the production of
Autor:
Masahiro Kimata, Satoshi Azuma
Publikováno v:
IEEJ Transactions on Industry Applications. 124:893-900
Autor:
Isao Serizawa, Naoki Inagaki, Masahiro Kimata, Michitaka Shichijo, Toshikazu Tsuji, Hiroichi Nagai, Toshinobu Kato, Masayuki Murata, Toru Miura
Publikováno v:
Allergology International, Vol 51, Iss 3, Pp 197-203 (2002)
Background Although β-adrenergic receptor agonists inhibit antigen-induced release of histamine, leukotrienes and prostaglandin D 2 from human lung fragments, dispersed human lung mast cells and human skin mast cells, subcellular mechanisms for the
Autor:
Hiroichi Nagai, Masahiro Kimata, Masako Tsunematsu, Itaru Yamaguchi, Naoki Inagaki, Toru Abe, Kanako Mito
Publikováno v:
Pharmacology. 62:17-22
Epicutaneous antigen challenge in passively sensitized mice with IgE produces a biphasic cutaneous response which peaks 1 h (immediate-phase reaction) and 24 h (late-phase reaction; LPR) after the antigen challenge. In this model, anaphylactic degran
Publikováno v:
Biochemical Pharmacology. 60:589-594
Human cultured mast cells (HCMC) secrete histamine, sulfidoleukotrienes (LTs), and prostaglandin D(2) (PGD(2)), and produce a variety of cytokines after aggregation of high-affinity receptors for IgE (FcepsilonRI). With respect to the mitogen-activat
Publikováno v:
Clinical & Experimental Allergy. 30:501-508
Background Flavonoids have a variety of activities including anti-allergic activities, and are known to inhibit histamine release from human basophils and murine mast cells. Objective The effects of luteolin, a flavone, on the immunoglobulin (Ig) E-m